Arlington Capital Partners Buys Avalign Technologies

Washington, D.C.-based private equity firm Arlington Capital Partners is buying Lake Forest, Ill.-based Avalign Technologies Holdings Inc. from Roundtable Healthcare Partners. Avalign is a full-service precision manufacturer of implants and instruments, specialty instrumentation, cutting tools, and cases and trays to the orthopedic medical device and specialty surgical markets.

“Avalign is an established leader in the large and growing orthopedic precision manufacturing market,” said Matt Altman, a partner at Arlington Capital said. “Recognized across the industry for its superior engineering and manufacturing capabilities, Avalign provides significant value to its [original equipment manufacturer] partners through design improvement, speed to market acceleration and cost reductions. We look forward to partnering with the highly talented Avalign management team to support the company through its next phase of growth.”

“We are extremely pleased to be partnering with Arlington Capital,” said Forrest Whittaker, CEO of Avalign. “Avalign is committed to improving patient outcomes by providing best-in-class medical devices through our industry leading end to end capabilities. We believe that Arlington Capital, which has deep expertise and an impressive track record in healthcare and precision manufacturing, is the ideal partner to help us achieve our goals. We would also like to thank RoundTable Healthcare Partners for all of their support and partnership to date.”

RoundTable Healthcare Partners founded Avalign in October 2005 through the purchase of Instrumed International, a German instrument manufacturer.  Since entering the business in 2005, RoundTable built Avalign from a niche, family-owned business into a platform with a complete suite of high-precision manufacturing capabilities and a reputation-building strategy consisting of organic growth and strategic acquisitions.